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ABSTRACT
The qualitative and quantitative analysis of an antibiotic drug, 5-amino-1 cyclopropyl-7 (cis-3, 5
dimethyl-l-piperazyl)-6,8- dihydro-1, 4 dihydroo4-oxo-3-quinoline carboxylic acid (Sparfloxacin, SFX) and
its pharmaceutical formulation i.e.sparx-100 tablet, has been done using polarographic and amperometric
methods. Complexation behavior of SFX with Fe(II), both in solid and liquid phases has been studied by
elemental analysis, IR.-spectra and polarographic and amperometric methods. SFX produces a single
cathodic reduction wave in 0.1 M ammonium tartrate (supporting electrolyte) at pH 6.0 .+-0.1. The wave is
diffusion controlled and wave height is proportional to the concentration of SFX. The complex is also
reversibly reduced at the electrode surface with diffusion-controlled kinetics. The stoichiometry of the Fe(II)-
SFX complex is 1:1. Antibacterial studies on the drug and its metal complex have been performed against
different bacteria. The observed results revealed the complex to be more potent in its antibacterial activity as
compared to the parent drug. On the basis of observed results it could be concluded that the prepared Fe(II)-
SFX complex may be recommended to the therapeutic experts for its possible use as a more potent antibiotic
drug.
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INTRODUCTION
SFX, 5-amino- cyclopropyl-7 (cis-3,5 dimethyl- l-piperazyl)-6,8- dihydro- 1, 4 dihydro-4-oxo-3-quinoline
carboxylic acid (an antibiotic drug) is used for the treatment of many diseases such as tuberculosis, skin
diseases, etc.I/oL 9. Nos. 1-2, 2002 Bio-lnorganic Studies on the Fe(ll)Sparfloxacin Con.tplex
Iron(II) plays a very important role in biological systems. It is an established fact that the oxygen
transport in-vivo takes place through th iron complex i..hmoglobin. Several other important roles of irons
are also well known.
The biochemical, pharmacological and medicinal importance of metal-drug complexes is very well
established /1,4/. In continuation to the work done in our laboratory on the studies of electrochemical,
bioinorganic, antibacterial and pharmacological behavior of some metal-drug complexes/5,6/the present
paper discusses the role of biomtal ion Fe(ll) in the physicochemieal and bioinorganie behavior of SFX and
deals with the said studies on th F(II)-SFX complex.
EXPERIMENTAL
Instrumentation
All the polarograms/voltammograms were recorded on an Elico (India) DC polarograph, model 357 and
an Elico (India) pulse polarograph, model CL-90, respectively, coupled with an x-y polarocard model LR-
101 and LR-101P. The polarographic cell consists of an electrode assembly having a dropping mercury
electrode (working electode), a saturated calomel electrode (reference electrode), and a coiled platinum wire
(auxiliary electrode). A Systronics digital pH meter-335 was used for the pH measurements. The IR spectrum
of solid complex was recorded using KBr pellets on an IR spectrophotometer Shimadzu, Japan, Model 470.
Chemicals and Reagents
The chemicals used were of Analar/BDH grade. The SFX (C 19 H :z2F :zN40 3) sample was supplied to us
as a free gift by Ranbaxy Laboratories Gurgaon, India. Doubly distilled water and absolute ethanol
(55:45v/v) was used as solvent, pH adjustments were made using dilute solutions of HCI, NaOH whenever
necessary.
Electrochemical Behavior SFX
Qualitative and quantitative studies on SFX were carried on by DCP/7/and DPP method. Experimental
sets were prepared by keeping overall ammonium tartrate concentration fixed at 0.1M. The SFX
concentration was varied from 0.0 mM to 1.0 mM. The pH of the test solutions was adjusted to 6.0. The
solution was deaerated with purified H2 gas. Polarograms were recorded keeping the initial potential set to
1.3 volts.
The analysis of SFX in pharmaceutical formulation i.e. sparx-100 (tablet) was performed by dissolving
the tablet in 100 ml of water alcohol (45:55 v/v) and following the earlier discussed polarographic and
amperometric procedures.Su’ati Jain et al. Metal-Based Drugs
Preparation ofComplex
For the study of stoichiometry and formation constant of the complex, Lingane’s polarographic method
was used. Experimental sets were prepared by keeping overall iron (metal ion) and potassium chloride
concentration fixed at lmM and 0.1M respectively. The ligand concentration was varied from 0.0 to 15 raM.
The pH of the test solution was adjusted to 5.0. The solution was deaerated with purified H2 gas. Polarograms
were recorded keeping the initial potential set to -1.1 volts.
The amperometric titrations were performed on a manually operated set-up equipped with a polyflex
galvanometer (sensitivity 8.1.10-9) and an Ajco vamier potentiometer. DME was used as an indicator
electrod a,d a calomel electrode served as reference electrode. The capillary characteristic of the DME had
a m2/3,
u6 value of 2.13 mg
2/3 sec
-/2 at 60cm effective height of mercury column, pH measurements were
made on a Systronics pH meter model 335 using a glass and a calomel electrode. All the measurements were
made at 25 C.
The experimental sets were prepared by taking different but known amounts of Fe(II) in the cell to which
an appropriate amount of KCI (supporting electrolyte ) was added to make its overall concentration 0.1M.
The pH was then adjusted to 5.0; it was then titrated against the standard solution of SFX (pH 5.0) at -1.6 V
vs saturated calomel electrode (the plateau potential of Fe(II)). After each addition of the titrant the current
was read on the galvanometer and the current versus volume of titrant added was plotted.
Synthesis of the Solid Complex
A brown coloured solid complex was synthesized by refluxing the 1:1 aqueous solution of ferrous
ammonium sulphate and SFX solution in water and ethyl alcohol (55:45v/v) for about 5 hr. The
conplexation was marked by precipitation after reducing the volume of reaction mixture to one fourth of the
original volume .The product was filtered, washed, dried over P40!0 and stored.
The results of elemental (C, H, N and O) analysis on the drug and its Fe(II)-SFX were furnished by the
CDRI, Lucknow, India. The complexometric method was used for the estfination of iron in the complex/8/.
Biological Study of Fe(ll) SFX Complex
Biochemical applications are in demand nowadays. The activity of bacteria on several compounds gives
more important information about the complex. So it prompted us to screen the complex and precursors to
find out which part of the molecule is actually responsible for its physiological activity.
Antibacterial Studies
Raper’s paper disc method/9/was followed for the antibacterial screening of Fe(II)-SFX complex against
some pathogenic bacteria, viz. Staphylococcus aureus, Salmonella typhi, Basillus subtalis and Escheria coli.
The percentage inhibition was calculated using the following formula/9/.l’ol. 9, Nos. 1-_. 2002 Bio-lnorganic Studies on the Fe(ll)A.’pafloxacin Complex
a-b
% Inhibition * 100
where ’a’ represents the diameter of zone of inhibition for control and ’b’ for the complex.
RESULTS AND DISCUSSION
SFX produced a well defined polarographic wave/peak in 0.1M ammonium tartrate pH 6.0+0.1 with E ,
--1.45, Ep---1.49 V vs SCE. Its wave height was found to be proportional to the concentration of SFX (Fig
and 2). The polarographic analysis of SFX in the pharmaceutical formulation sparx-100, tablet revealed
100rag SFX per tablet, which is in good agreement with that claimed by the manufacturer.
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Fig. 1" Differential pulse polarogram of Sparfloxacin in 0.1 M ammonium tartrate pH 6.0 +/- 0.1. a. 0.125
raM, b. 0.250 mM, c. 0.50 raM.
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Fig. 2: Direct current polarogram of Sparfloxacin in 0.1 M ammonium tartrate pH 6.0 + 0.1. a. 0.125 raM,
b. 0.250 raM, c. 0.50 raM.S’ti ..hdn et al. Metal-Based Drugs
Polarographic Study ofM" L Complexation Equilibrium
Both Fe(ll) and its complex with SFX ligand produce a reversible two- electron reduction wave in 0.1M
KCI at pH 5.0. The number of electrons involved in the electrode reaction was confirmed by the plots of log
(i/id-i) VS E. The plot of ia vs /h co.-. proved the reduction to be diffusion-controlled.
The complex formation between Fe(ll) and SFX (Fig. 3) was revealed by the shift in half-wave potential
of Fe(ll) metal ion to a more elect,’onegative value and decrease in the height of the diffusion current with
gradual increase of the SFX concentration.
Plots of A E/2 (shift in the E/2) (E/2)c- (E /2) against log C (logarithm of the concentration of the
ligand) realted in a linear plot. The linear plot showed the formation of single complex species in solution.
Lingane/I 1/treatment of the observed polarographic data revealed I:IFe(II)-SFX complex formation with
formation constant log 3-3.9 (Fig. 4).
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Fig. 3: Direct current polarogram of Fe(ll) in 0.1 M KCI, pH 5.0 +/- 0.1 presence of Sparfloxacin. a. 0.0 raM,
b. 0.125 mM, c. 0.250 raM, d. 0.50 raM, e. 0.75 mM.
[-E 1,360
L340
4.0 3.9 3.8 3,7 6, 3.5 M
1o$ SFX CO.{CE.N’FRATIO
Fig. 4" Plot of-El/2 vs log Cx for Fe(ll)-Sparfloxacin complex.Vol. 9, Nos. I-2, 2002 Bio-lnorganic Studies on the Fe(ll)A.’patfloxacin Complex
Amperometric Determination ofSFX with Fe(ll)
Fe(ll) gives a well defined polarographic wave in 0.1M KCI at pH 5.0 + 0.1. The diffusion current was
found proportional to its concentration. The SFX does not produce any wave under the said experimental
condition. The plateau potential for the polarographic wave of Fe(II), 1.6 V vs Hg pool anode was applied
for carrying out amperometric titration. Fe (11) was taken as titrate, and the drug solution was taken as titrant.
The current volume plots resulted in an L shaped curve (Fig. 5). The end point as located by a graphic
method revealed a metal to drug ratio of I:1, which is in agreement with the author’s observation on the
metal:ligand complexation equilibrium using a polarographic method.
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Fig. 5" Amperometric titration of 10 mM 50 ml analyte Fe(II) with 2.5 mM SFX in 0.1 M potassium
chloride, pH 5.0 +/- 0.1.
Elemental Analysis
The results of elemental analysis on the drug and its complex with Fe(II) are depicted in Table 1. The
table revealed a 1"1 metal:drug ratio in the complex, which supports the author’s finding using polarographic
and amperometric methods.
IR-Spectra
Some important frequencies of IR signals of SFX and its Fe(ll) complex are listed in Table 2. The
stretching vibration due to (C=O) and (N-H) in the IR spectrum of the drug appear as a band at 1710 cm
"1 and
a doublet between 3300-3450 cm" /12,13/ and are shifted as a band at 1700 cm" and as a broad and reduced
band at 3150 cm" respectively, in the spectrum of Fe(II)-SFX complex. Thus, it could be concluded that
oxygen of carboxylic acid and nitrogen ofN-H group are involved in complex formation with the metal ion.,S’’ati .hlin eta/. Metal-Based Drugs
Antibacterial Studies
Antibacterial activity of the compound (0.5M Conc.) is depicted in Table 3 showing the various bacteria.
This complex was found to be more toxic against bacteria. In the case of Basillus subtalis, Salmonella typhi,
Escheria coli and Staphylococcus aureus, the percentage inhibition due to Fe(II)-SFX complex is -18.0,
16.6, 15.7 and 13.6 respectively over the parent drug control.
Table 1
Analytical Data ofSFX and Fe(II) SFX Complex % Calculated/Found
Compound
SFX
Fe(II)-SFX
complex
Metal
12.74
(12.71)
58.1
(58.5)
51.16
(51.19)
H
5.65
(5.68)
4.9
(4.93)
N
9.69
(9.72)
8.0
(7.8)
O
12.23
(12.27)
10.7
(10.9)
14.28
(14.35)
12.5
(12.9)
Table 2
Principal IR Frequencies (cm1) ofSFX and Fe(II)-SFX Complex
SFX Assignment FE(II)-SFX
920 N-H wagging vibration 920
1025 Region of C-F absorption 1025
1290 C=O stretching aromatic conjugation 1290
1435 C-N ring stretching 1435
1630 C=C stretching in ring six member vibration 1630
1700 C=O stretching cyclic (COOH) 1720
3450 Symmetrical N-H stretching 3150
Table 3
Antibacterial Activity of Fe(II)-SFX Complex
Micro-Organism Bacteria
Staphylococcus aureus
Salmonell typhi
Escheria coli
Basillus subtitis
Zone of Inhibition
Drug(a)"
14
18
12
16
Complex(b)**
17
23
14
19
% Inhibition
-21.4
-27.7
-16.6
-18.75
Including diameter of filter paper disc 6 mm
Drug
Drug-metal complex mg/ml (equivalent mg/ml)1"ol. 9, Nos. 1-2. 2002 Bio-hlorgaftic Studies on the Fe(ll)Spatfloxacin Complex
CONCLUSION
The polarographic/amperometric methods could be successfully used for the qualitative and quantitative
analysis of SFX in pharmaceutical formulation, i.e. sparx-100, and could be recommended for its use for
quality control purposes in the drug industry. In addition, in view of the increased bacterial potency it may be
recommended to the therapeutic experts for its possible use as a more potent antibiotic drug.
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